Mark Sheptoff Financial Planning’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
1,578
+1,525
| +2,877% | +$164K | 0.09% | 97 |
|
|
2025
Q1 | $5.35K | Hold |
53
| – | – | ﹤0.01% | 370 |
|
|
2024
Q4 | $4.73K | Hold |
53
| – | – | ﹤0.01% | 371 |
|
|
2024
Q3 | $4.44K | Sell |
53
-473
| -90% | -$39.6K | ﹤0.01% | 369 |
|
|
2024
Q2 | $40.5K | Buy |
526
+473
| +892% | +$36.4K | 0.02% | 192 |
|
|
2024
Q1 | $3.63K | Hold |
53
| – | – | ﹤0.01% | 346 |
|
|
2023
Q4 | $3.06K | Hold |
53
| – | – | ﹤0.01% | 346 |
|
|
2023
Q3 | $2.8K | Hold |
53
| – | – | ﹤0.01% | 330 |
|
|
2023
Q2 | $2.87K | Hold |
53
| – | – | ﹤0.01% | 338 |
|
|
2023
Q1 | $2.65K | Hold |
53
| – | – | ﹤0.01% | 335 |
|
|
2022
Q4 | $2.45K | Hold |
53
| – | – | ﹤0.01% | 342 |
|
|
2022
Q3 | $2K | Hold |
53
| – | – | ﹤0.01% | 321 |
|
|
2022
Q2 | $2K | Hold |
53
| – | – | ﹤0.01% | 333 |
|
|
2022
Q1 | $2K | Hold |
53
| – | – | ﹤0.01% | 376 |
|
|
2021
Q4 | $2K | Buy |
+53
| New | +$2K | ﹤0.01% | 403 |
|
|
2021
Q1 | – | Sell |
-280
| Closed | -$10K | – | 378 |
|
|
2020
Q4 | $10K | Hold |
280
| – | – | 0.01% | 267 |
|
|
2020
Q3 | $11K | Hold |
280
| – | – | 0.01% | 227 |
|
|
2020
Q2 | $10K | Hold |
280
| – | – | 0.01% | 258 |
|
|
2020
Q1 | $9K | Hold |
280
| – | – | 0.01% | 242 |
|
|
2019
Q4 | $13K | Hold |
280
| – | – | 0.01% | 259 |
|
|
2019
Q3 | $11K | Buy |
+280
| New | +$11K | 0.01% | 261 |
|
|
2014
Q3 | – | Sell |
-564
| Closed | -$7K | – | 339 |
|
|
2014
Q2 | $7K | Hold |
564
| – | – | 0.01% | 295 |
|
|
2014
Q1 | $8K | Buy |
+564
| New | +$8K | 0.01% | 291 |
|